MetaCap

Jade Biosciences (JBIO) vs Kardigan (KARD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Kardigan is the larger company by market cap ($1.08 billion vs $1.06 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

JBIO-8.98%KARD-47.55%
+52%-0%-52%
Jun 18, 20261 yearNov 20, 2026
JBIO-8.98%KARD-47.55%
+52%-0%-52%
Jun 15, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

JBIO versus KARD key metrics
MetricJBIOKARD
Share price$15.31$11.54
Market cap$1.06B$1.08B
1-day change+1.66%-7.83%
YTD return-0.78%—
1-year return+27.58%—
5-year return-96.69%—
EPS (TTM)$-1.83$-6.24
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-127.41M—
52-week high$28.00$27.00
52-week low$11.32$11.49
Distance from 52-week high-45.32%-57.26%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+222.53%+255.29%
Average volume917.21K625.83K
Shares outstanding69.19M93.60M
Employees55241
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Jade Biosciences

JBIO stock →

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 55 employees

About Kardigan

KARD stock →

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 241 employees

JBIO vs KARD FAQ

Which is bigger, Jade Biosciences or Kardigan?

Kardigan (KARD) is larger, with a market capitalization of $1.08B compared with $1.06B for Jade Biosciences (JBIO).

Are Jade Biosciences and Kardigan in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons